Keyword: Drug and Chemical Associated Technologies Association (DCAT)
News
22.06.2017
- In unusually open criticism of a sector journalists report on widely, the digital communications platform ISEBOX has accused the international pharmaceutical industry of failing to...
News
19.05.2017
- Biogen has licensed a late-stage stroke drug from Remedy Pharmaceuticals. The US biotech will make an upfront payment of $120 million for Cirara (intravenous glyburide), as well as...
News
16.05.2017
- Major US drugmaker Pfizer is collaborating with Sangamo Therapeutics to develop and commercialize gene therapy programs for the rare blood disorder hemophilia A. The agreement...
News
09.05.2017
- For as much as five months, US drugmaker Pfizer will provide its breast cancer drug palbociclib for free to the England arm of the UK’s National Health Service (NHS). The decision...
News
08.05.2017
- Major drug makers Allergan and Novartis are collaborating to test a new combination therapy for non-alcoholic steatohepatitis (NASH), a progressive form of fatty liver disease said...
News
24.04.2017
- After a major slowdown in 2016, new drug approvals by the US Food and Drug Administration rose sharply in the first quarter of 2017, according to a report by EP Vantage. Up to mid...
News
18.04.2017
- The US Food and Drug Administration (FDA) has approved NuvOx Pharma’s application to proceed with Phase 2 clinical trials for an Investigational New Drug (IND) to initiate a Phase...
News
07.04.2017
- Japan’s Astellas Pharma has agreed to buy privately held Belgian drug developer Ogeda in a transaction worth up to €800 million. The acquisition expands the Tokyo-headquartered...
